AMAG Pharma (AMAG) discloses FDA requested additional data on frequent dosing of Vyleesi
Tweet Send to a Friend
AMAG Pharma (NASDAQ: AMAG) disclosed in an SEC filing:
As part of AMAG Pharmaceuticals, Inc.’s (the “Company”) discussions with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
As part of AMAG Pharmaceuticals, Inc.’s (the “Company”) discussions with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
